Loading ETF profile…
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| AMGN | Amgen Inc | 15.57% | $57.80M |
| GILD | Gilead Sciences Inc | 13.49% | $50.06M |
| VRTX | Vertex Pharmaceuticals Inc | 9.15% | $33.95M |
| REGN | Regeneron Pharmaceuticals Inc | 6.56% | $24.34M |
| RVMD | Revolution Medicines Inc | 5.09% | $18.88M |
| ARGX | Argenx Se | 4.87% | $18.09M |
| NTRA | Natera Inc | 4.53% | $16.83M |
| IQV | Iqvia Holdings Inc | 4.07% | $15.10M |
| ALNY | Alnylam Pharmaceuticals Inc | 3.91% | $14.51M |
| BIIB | Biogen Inc | 3.53% | $13.09M |
| ILMN | Illumina Inc | 3.17% | $11.77M |
| MRNA | Moderna Inc | 3.12% | $11.59M |
| UTHR | United Therapeutics Corp | 3.03% | $11.23M |
| ONC | Beone Medicines Ltd | 2.90% | $10.77M |
| INSM | Insmed Inc | 2.73% | $10.12M |
| INCY | Incyte Corp | 2.45% | $9.08M |
| NBIX | Neurocrine Biosciences Inc | 2.13% | $7.89M |
| BNTX | Biontech Se | 2.02% | $7.48M |
| ICLR | Icon Plc | 1.67% | $6.18M |
| BMRN | Biomarin Pharmaceutical Inc | 1.41% | $5.23M |
| CRL | Charles River Laboratories Internationa | 1.32% | $4.89M |
| TECH | Bio-Techne Corp | 1.31% | $4.86M |
| QGEN | Qiagen Nv | 1.08% | $4.01M |
| TEM | Tempus Ai Inc | 0.88% | $3.26M |
| — | Other/Cash | 0.05% | $170.82K |